8-K Announcements
6Material company update
Jul 26, 2022·SEC
Material company update
Jul 15, 2022·SEC
Material company update
Jul 5, 2022·SEC
Waldencast plc(WALD)Earnings, Financials & Key Ratios
WALD•NASDAQ
$1.72
Price updated Jul 7, 2026
AboutWaldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.Show more
- Revenue$272M-0.7%
- EBITDA-$2M-274.1%
- Net Income-$230M-441.3%
- EPS (Diluted)-2.01-415.4%
- Gross Margin45.52%-5.4%
- EBITDA Margin-0.92%-275.2%
- Operating Margin-22.67%-6.0%
- Net Margin-84.44%-444.9%
- ROE-37.36%-559.8%
WALD Price & Volume
Waldencast plc (WALD) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operating Losses Threaten Long-term Solvency
Investment Thesis • Updated 2025Q4
VerdictNegative
Growth:Decelerating
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Liquidity and solvency pressure
Key Thesis Takeaways
- Waldencast faces a challenging outlook characterized by decelerating revenue growth, which contracted by 1.7% in 2025Q4, and a failure to achieve necessary operating leverage.
- The company's inability to convert accounting figures into positive cash flow, evidenced by a 2025Q4 OCF/NI ratio of 0.02, suggests that the current business model remains fundamentally unsustainable.
- Investors should monitor the company's thin liquidity buffer of $31.9M in cash, which may necessitate dilutive financing or further asset divestitures to address the ongoing erosion of shareholder equity.
Verdict Logic
the company's inability to generate positive cash flow, evidenced by a -1.5% FCF margin in 2025Q4, combined with a net margin of -43.1%, indicates severe risks to long-term capital preservation.
WALD Growth Metrics
Waldencast plc (WALD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years23.57%
3 Years17.87%
TTM42.07%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-31.75%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-31.28%
Return on Capital
10 Years-7.4%
5 Years-7.4%
3 Years-7.32%
Last Year-7.52%
WALD Recent Earnings
Waldencast plc (WALD) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 0/12 qtrs (0%)●Beat Revenue 7/12 qtrs (78%)
Q2 2026Latest
Mar 13, 2026Metric
Actual
Est
EPS
$0.51-200.0%
$0.17
Rev
$140M+111.3%
$66M
Q1 2026
Jan 6, 2026Metric
Actual
Est
EPS
$0.09-20.0%
$0.07
Rev
$66M-1.9%
$68M
Q4 2025
Nov 24, 2025Metric
Actual
Est
EPS
$1.51-1269.5%
$0.11
Rev
$132M+95.1%
$68M
Q2 2025
May 13, 2025Metric
Actual
Est
EPS
$0.17-214.8%
$0.05
Rev
$65M-3.9%
$68M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 13, 2026 | $0.51vs $0.17-200.0% | $140Mvs $66M+111.3% |
| Q1 2026 | Jan 6, 2026 | $0.09vs $0.07-20.0% | $66Mvs $68M-1.9% |
| Q4 2025 | Nov 24, 2025 | $1.51vs $0.11-1269.5% | $132Mvs $68M+95.1% |
| Q2 2025 | May 13, 2025 | $0.17vs $0.05-214.8% | $65Mvs $68M-3.9% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Waldencast plc (WALD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.72 | $203.37M | -0.86 | -0.66% | -84.44% | -37.36% | — | |
| $75.34 | $4.48B | 171.23 | 24.59% | 3.34% | 5.16% | — | |
| $2.23 | $1.96B | -5.07 | -3.68% | -9.26% | -14.13% | — | |
| $122.25 | $3.92B | 23.33 | 2.49% | 13.46% | 18.37% | — | |
| $1.11 | $143.86M | -6.94 | -10.02% | -2.03% | -9.41% | — | |
| $84.44 | $30.49B | -26.81 | -8.46% | -1.67% | -6.29% | — |
Compare WALD vs Peers
Waldencast plc (WALD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
WALD SEC Filings & Documents
Waldencast plc (WALD) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when WALD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
WALD Frequently Asked Questions
Waldencast plc (WALD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Waldencast plc's revenue?
Waldencast plc (WALD) reported $545.9M in revenue for fiscal year 2025. This represents a 478% increase from $94.4M in 2020.
How fast is Waldencast plc growing?
Waldencast plc (WALD) saw revenue decline by 0.7% over the past year.
Is WALD profitable?
Waldencast plc (WALD) reported a net loss of $272.2M for fiscal year 2025.
Dividend & Returns
What is WALD's return on equity?
Waldencast plc (WALD) has a return on equity (ROE) of -37.4%. Negative ROE indicates the company is unprofitable.
What is Waldencast plc's free cash flow?
Waldencast plc (WALD) had negative free cash flow of $27.8M in fiscal year 2025, likely due to heavy capital investments.